All stock lists
Dianthus Therapeutics, Inc. /DE/ (NASDAQ:DNTH)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
79.25+2.47 (+3.22%)
Insider Score
––Not scored
DNTH Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
DNTH Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 761.00 K | 463.00 K | 284.00 K | 396.00 K | 193.00 K | 1.16 M |
| Revenue Growth (YoY) | 294.30 % | -60.19 % | -78.58 % | -81.77 % | -89.64 % | 33.07 % |
| Cost of Revenue | 0.00 | 76.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 761.00 K | 387.00 K | 284.00 K | 396.00 K | 193.00 K | 1.16 M |
| SG&A Expense | 13.56 M | 12.47 M | 9.93 M | 8.20 M | 8.87 M | 7.34 M |
| R&D Expense | 48.69 M | 34.53 M | 59.90 M | 32.49 M | 26.25 M | 27.00 M |
| Operating Expenses | 62.24 M | 46.92 M | 69.83 M | 40.68 M | 35.12 M | 34.34 M |
| Operating Income | -61.48 M | -46.53 M | -69.54 M | -40.29 M | -34.93 M | -33.18 M |
| Pretax Income | -50.22 M | -40.83 M | 97.91 M | -36.77 M | -31.63 M | -29.51 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -50.22 M | -40.83 M | 97.91 M | -36.77 M | -31.63 M | -29.51 M |
| EPS (Basic) | -0.90 | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 |
| EPS (Diluted) | -0.90 | -0.85 | 2.59 | -0.97 | -0.88 | -0.82 |
| Shares Outstanding | 56.03 M | 48.03 M | 37.79 M | 37.79 M | 35.82 M | 35.79 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.